4.5 Review

Control of autoimmune CNS inflammation by astrocytes

Journal

SEMINARS IN IMMUNOPATHOLOGY
Volume 37, Issue 6, Pages 625-638

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00281-015-0515-3

Keywords

Multiple sclerosis; Astrocyte; Cytokine; Chemokine; Blood-brain barrier

Funding

  1. National Institutes of Health
  2. National Multiple Sclerosis Society
  3. International Progressive MS Alliance
  4. American Cancer Society
  5. Mallinckrodt Pharmaceuticals
  6. German Research Foundation (DFG) [RO4866-1/1]

Ask authors/readers for more resources

Multiple sclerosis is a neurologic disease caused by immune cell infiltration into the central nervous system, resulting in gray and white matter inflammation, progressive demyelination, and neuronal loss. Astrocytes, the most abundant cell population in the central nervous system (CNS), have been considered inert scaffold or housekeeping cells for many years. However, recently, it has become clear that this cell population actively modulates the immune response in the CNS at multiple levels. While being exposed to a plethora of cytokines during ongoing autoimmune inflammation, astrocytes modulate local CNS inflammation by secreting cytokines and chemokines, among other factors. This review article gives an overview of the most recent understanding about cytokine networks operational in astrocytes during autoimmune neuroinflammation and highlights potential targets for immunomodulatory therapies for multiple sclerosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available